secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001437749-25-016264
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity CEO to present company overview at Pharma Partnering Summit US on May 14-15
--------------------------------------------------------------------------------

- CEO Thomas H. Jensen will deliver a company overview on stenoparib (dual PARP/WNT inhibitor) and DRP® platform.
- One-on-one meetings will be conducted at the event in San Diego, CA on May 14-15, 2025.
- Participation is a standard business development and licensing conference activity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925016264/0001437749-25-016264-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925016264/allr20250512_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-016264

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer